Mineralys Therapeutics
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Mineralys Therapeutics?
Mineralys Therapeutics is a French Biotech company, currently owned by Andera Partners since 2022.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Andera PartnersBioDiscovery 6 · 2022 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2022 · present
Ysios Capital PartnersExited 2023
2022 · 2023(1yr) · Ysios BioFund III · 2020 · Life Sciences VC
IPO
Ysios Capital Partners took Mineralys Therapeutics public via IPO in 2023 after 1 year.
Andera PartnersActive
2022 · present(4yr) · BioDiscovery 6 · 2022 · VC
More from BioDiscovery 6
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Mineralys Therapeutics?
Mineralys Therapeutics is currently owned by Andera Partners, through BioDiscovery 6, since 2022.
When did Andera Partners acquire Mineralys Therapeutics?
Andera Partners acquired Mineralys Therapeutics in 2022.
Who has owned Mineralys Therapeutics over time?
Mineralys Therapeutics has been through 2 private-equity ownership periods: Ysios Capital Partners · via Ysios BioFund III · 2022–2023 · (IPO); Andera Partners · via BioDiscovery 6 · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue